Celestica Inc (TSE:CLS) (NYSE:CLS) rose 2% on Friday . The stock traded as high as C$12.69 and last traded at C$12.69. Approximately 264,075 shares changed hands during trading, a decline of 28% from the average daily volume of 367,781 shares. The stock had previously closed at C$12.44.
CLS has been the topic of several recent research reports. Royal Bank of Canada cut their target price on shares of Celestica to C$16.50 and set a “sector perform” rating on the stock in a research note on Friday, October 27th. BMO Capital Markets reaffirmed a “market perform” rating and set a C$12.50 target price on shares of Celestica in a research note on Friday, October 27th. TD Securities cut their target price on shares of Celestica to C$14.75 and set a “hold” rating on the stock in a research note on Friday, October 27th. Finally, Scotiabank cut their target price on shares of Celestica from C$14.00 to C$11.00 and set a “sector perform” rating on the stock in a research note on Thursday, January 25th.
The firm has a market capitalization of $1,780.00, a PE ratio of 14.26 and a beta of 0.36.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/02/celestica-cls-stock-price-up-2.html.
Celestica Company Profile
Celestica Inc is a provider of supply chain solutions. The Company operates in electronics manufacturing services business segment. The Company offers a range of services to its customers, including design and development, engineering services, supply chain management, new product introduction, component sourcing, electronics manufacturing, assembly and test, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics and after-market repair and return services.
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.